Cargando…
LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors
Triple‐negative breast cancer (TNBC) is the breast cancer subtype with the worst prognosis. New treatments improving the survival of TNBC patients are, therefore, urgently required. We performed a transcriptome microarray analysis to identify new treatment targets for TNBC. We found that low‐density...
Autores principales: | Maire, Virginie, Mahmood, Faisal, Rigaill, Guillem, Ye, Mengliang, Brisson, Amélie, Némati, Fariba, Gentien, David, Tucker, Gordon C., Roman‐Roman, Sergio, Dubois, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346259/ https://www.ncbi.nlm.nih.gov/pubmed/30575334 http://dx.doi.org/10.1002/cam4.1923 |
Ejemplares similares
-
LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
por: Maubant, Sylvie, et al.
Publicado: (2018) -
Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019) -
Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
por: Maubant, Sylvie, et al.
Publicado: (2015) -
TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
por: Maire, Virginie, et al.
Publicado: (2013) -
PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
por: Suresh, Samyuktha, et al.
Publicado: (2022)